
Caixa Capital Risc et al. invest in Pevesa Biotech
Caixa Capital Risc has led a €1.6m funding round for Spanish biotech firm Pevesa Biotech.
Co-funding was provided by current Pevesa shareholders Suanfarma Biotech and Milar Ventures. Caixa invested through Caixa Innvierte Industria, an industrial technology fund containing €23m.
The fresh funding will enable the company to expand its production facilities and sales network.
Company
Founded in 1996 and based in Seville, Pevesa Biotech is a biotechnology firm that focuses on plant proteins, with applications in organic farming and food.
Pevesa has 17 members of staff and a €2.3m turnover, which it intends to triple in the next four years.
People
Carlos Trenchs is a director at Caixa.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater